• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Medexus Pharmaceuticals Inc (OP: MEDXF )

    1.940 +0.002 (+0.13%)
    Streaming Delayed Price Updated: 2:27 PM EDT, Oct 11, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,300
    Open 1.940
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 1.938
    Today's Range 1.940 - 1.940
    52wk Range 1.060 - 2.350
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
    From Medexus Pharmaceuticals Inc
    Via GlobeNewswire
    Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update
    Annual revenue expected to exceed US$107 million for fiscal year ended March 31, 2023, an all-time record, including fiscal Q4 2023 revenue of at least US$28 million 
    From Medexus Pharmaceuticals Inc
    Via GlobeNewswire

    Performance

    YTD
    +1.04%
    +1.04%
    1 Month
    N/A
    N/A
    3 Month
    +14.05%
    +14.05%
    6 Month
    +70.18%
    +70.18%
    1 Year
    N/A
    N/A

    More News

    Read More
    Medexus Announces New License Deal for Topical Terbinafine
    From Medexus Pharmaceuticals Inc
    Via GlobeNewswire
    Medexus Announces US$58.5 million in New Credit Facilities
    From Medexus Pharmaceuticals Inc
    Via GlobeNewswire
    Medexus Pharmaceuticals Inc. (TSX: MDP) (OTCQX: MEDXF) Featured in Coverage of the 35th Annual Roth Conference
    Via Investor Brand Network
    Medexus to Participate in 35th Annual Roth Conference
    From Medexus Pharmaceuticals Inc
    Via GlobeNewswire
    Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022
    From Medexus Pharmaceuticals Inc
    Via GlobeNewswire
    Medexus Welcomes Two New Board Members
    From Medexus Pharmaceuticals Inc
    Via GlobeNewswire
    Medexus Secures Public Reimbursement for Cuvposa® in Quebec
    From Medexus Pharmaceuticals Inc
    Via GlobeNewswire
    Medexus Schedules Third Fiscal Quarter 2023 Conference Call
    From Medexus Pharmaceuticals Inc
    Via GlobeNewswire
    Medexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Update
    From Medexus Pharmaceuticals Inc
    Via GlobeNewswire
    Medexus Announces Strongest Quarter in Company History with Fiscal Q2 2023 Revenue of US$27.7 Million, a 55% Increase Over Fiscal Q2 2022
    From Medexus Pharmaceuticals Inc
    Via GlobeNewswire
    Medexus Schedules Second Quarter 2023 Conference Call
    From Medexus Pharmaceuticals Inc
    Via GlobeNewswire
    Medexus Announces Preliminary Revenue Results for Second Fiscal Quarter 2023
    From Medexus Pharmaceuticals Inc
    Via GlobeNewswire
    Medexus and MidCap Agree to Increase in MidCap’s Revolving Loan Commitment Amount
    From Medexus Pharmaceuticals Inc
    Via GlobeNewswire
    36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022
    From MicroCap Rodeo
    Via AccessWire
    Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
    From Stock News Now
    Via AccessWire
    Making a Difference When You Invest? Medexus Says It Improves Lives
    Via Benzinga
    Sidoti Microcap Virtual Conference
    From Sidoti & Company, LLC
    Via AccessWire
    Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2021
    Via Benzinga
    Medexus Pharmaceuticals to Present at the SNN Network Summer Virtual Event on Thursday, August 19, 2021
    From Medexus Pharmaceuticals Inc.
    Via AccessWire
    Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
    From Stock News Now
    Via AccessWire
    Topics Cannabis
    Exposures Cannabis
    Sidoti Microcap Virtual Conference
    From Sidoti & Company, LLC
    Via AccessWire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.